Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and ...

The weekend's resignation announcement of FDA official Peter Marks hit biotech stocks on Monday and sent Wall Street into a frenzy of concern over the future of biopharma approvals in the near term.

Evaxion Biotech (EVAX) shares fell over 25% premarket on Thursday after the company priced an offering to raise $10.8M. The sale comprises 3,997,361 of the company's American Depositary Shares and ...